Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
WRN RecQ like helicase | 0.524 | 0.808 | 2.6E-34 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 1999 | 2019 | ||||||||
|
von Hippel-Lindau tumor suppressor | 0.443 | 0.846 | 8.0E-02 |
|
group | 0.400 | None | 0.959 | 0 | 0 | 1989 | 2019 | ||||||||
|
UDP glucuronosyltransferase family 1 member A1 | 0.464 | 0.769 | 3.3E-06 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 2000 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.400 | None | 0.966 | 0 | 0 | 1986 | 2020 | ||||||||
|
thiopurine S-methyltransferase | 0.593 | 0.692 | 7.1E-06 |
|
group | 0.400 | None | 0.833 | 0 | 0 | 2000 | 2018 | ||||||||
|
SUZ12 polycomb repressive complex 2 subunit | 0.529 | 0.577 | 1.00 |
|
group | 0.360 | None | 1.000 | 0 | 0 | 2009 | 2015 | ||||||||
|
splicing factor 3b subunit 1 | 0.511 | 0.731 | 1.00 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 2011 | 2020 | ||||||||
|
SET domain containing 2, histone lysine methyltransferase | 0.424 | 0.846 | 1.00 |
|
group | 0.400 | None | 0.988 | 0 | 0 | 1997 | 2020 | ||||||||
|
serine/threonine kinase 11 | 0.435 | 0.808 | 0.99 |
|
group | 0.400 | None | 0.968 | 0 | 0 | 1998 | 2019 | ||||||||
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.975 | 0 | 0 | 1992 | 2020 | ||||||||
|
phosphoinositide-3-kinase regulatory subunit 1 | 0.477 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.923 | 0 | 0 | 2001 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
group | 0.400 | None | 0.986 | 0 | 0 | 1999 | 2020 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
group | 0.400 | None | 0.977 | 0 | 0 | 1997 | 2020 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 1988 | 2020 | ||||||||
|
notch receptor 1 | 0.369 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.943 | 0 | 0 | 1999 | 2019 | ||||||||
|
myogenic differentiation 1 | 0.569 | 0.654 | 0.15 |
|
group | 0.370 | None | 1.000 | 0 | 0 | 2001 | 2020 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
group | 0.600 | None | 0.979 | 0 | 0 | 1984 | 2020 | ||||||||
|
mutS homolog 3 | 0.474 | 0.769 | 7.4E-31 |
|
group | 0.400 | None | 0.903 | 0 | 0 | 1998 | 2019 | ||||||||
|
mitogen-activated protein kinase kinase 1 | 0.439 | 0.846 | 0.90 |
|
group | 0.400 | None | 0.946 | 0 | 0 | 2002 | 2019 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
group | 0.400 | None | 0.966 | 0 | 0 | 1991 | 2020 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.982 | 0 | 0 | 1995 | 2020 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
group | 0.400 | None | 0.977 | 0 | 0 | 1992 | 2020 | ||||||||
|
lysine demethylase 6A | 0.498 | 0.769 | 1.00 |
|
group | 0.600 | None | 1.000 | 0 | 0 | 2009 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.600 | None | 0.972 | 0 | 0 | 1987 | 2020 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
group | 0.400 | None | 0.941 | 0 | 0 | 1996 | 2019 |